Phibro Animal Health (PAHC) reported solid results for fiscal 2023 with Q2 net sales rising 5.1% from the prior year to $244.6 million, which was 1.4% ahead of the $241.3 million analysts had been projecting. This beat was led by the company’s core Animal Health business, which delivered its...
